Meningococcal ABCWY vaccine meets primary endpoints in phase 3 trial
If approved by the FDA, this 5-in-1 investigational candidate could provide the broadest meningococcal serogroup coverage.
England eliminates mother-to-child transmission of hepatitis B
In doing so, the country met the new target of the World Health Organization.
2 Clarke Drive Cranbury, NJ 08512